NEJM · 2026
Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310
Made by Synapse from the paper’s published results and the public expert discussion around it.
NEJM · 2026
Made by Synapse from the paper’s published results and the public expert discussion around it.